140 related articles for article (PubMed ID: 12917098)
1. Why I initiate therapy with two insulin sensitizers in patients with type 2 diabetes.
Bell DS
Endocr Pract; 2003; 9(1):98-101. PubMed ID: 12917098
[No Abstract] [Full Text] [Related]
2. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
Blonde L; Sandberg MI; Guthrie RD
Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262
[No Abstract] [Full Text] [Related]
3. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
4. Combination therapy in type 2 diabetes: the role of repaglinide.
Moses R
J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
[No Abstract] [Full Text] [Related]
5. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
6. Insulin sensitizers for polycystic ovary syndrome.
Baillargeon JP; Iuorno MJ; Nestler JE
Clin Obstet Gynecol; 2003 Jun; 46(2):325-40. PubMed ID: 12808383
[No Abstract] [Full Text] [Related]
7. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
Lotz N
MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
[No Abstract] [Full Text] [Related]
8. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
Krentz AJ; Bailey CJ; Melander A
BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
[No Abstract] [Full Text] [Related]
9. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
[TBL] [Abstract][Full Text] [Related]
10. [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
Satoh J
Nihon Rinsho; 2003 Jul; 61(7):1224-9. PubMed ID: 12877089
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
12. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
Iuorno MJ; Nestler JE
Diabetes Obes Metab; 1999 May; 1(3):127-36. PubMed ID: 11220291
[No Abstract] [Full Text] [Related]
13. Insulin sensitizers: past, present and future.
Siddiqui NI
Mymensingh Med J; 2005 Jan; 14(1):1-2. PubMed ID: 15695942
[No Abstract] [Full Text] [Related]
14. Insulin resistance: site of the primary defect or how the current and the emerging therapies work.
Kolaczynski JW; Caro JF
J Basic Clin Physiol Pharmacol; 1998; 9(2-4):281-94. PubMed ID: 10212839
[TBL] [Abstract][Full Text] [Related]
15. [Rosiglitazone (BRL-49653)].
Oka Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
[No Abstract] [Full Text] [Related]
16. [Clinical efficacy of Pioglitazone (AD-4833)].
Kaneko T; Baba S
Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
[No Abstract] [Full Text] [Related]
17. [Thiazolidinediones].
Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
[No Abstract] [Full Text] [Related]
18. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
19. [Diabetes mellitus].
Kawano M; Kanazawa Y
Nihon Rinsho; 2000 Feb; 58(2):421-5. PubMed ID: 10707569
[TBL] [Abstract][Full Text] [Related]
20. [Insulin sensitizer. A new therapy option for type 2 diabetic patients].
Filz HP
MMW Fortschr Med; 2000 Sep; 142(38):31-3. PubMed ID: 11050888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
